References
Bamford NS, Trojaborg W, Sherbany AA, De Vivo DC. (2002). Congenital Guillain-Barré syndrome associated with maternal inflammatory bowel disease is responsive to intravenous immunoglobulin. European Journal of Paediatric Neurology. 6(2):115-119.
Church Potter R, Kaneene JB. (2003). A descriptive study of Guillain-Barré Syndrome in high and low Campylobacter jejuni incidence regions of Michigan: 1992-1999. Neuroepidemiology. 22:245-248.
Ghezzi A, Zaffaroni M. (2001). Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurological Sciences. 22(Suppl 2):S117-122.
Gondim FA, Brannagan TH 3rd, Sander HW, Chin RL, Latov N. (2005). Peripheral neuropathy in patients with inflammatory bowel disease. Brain. 128(Pt 4):867-879.
Hughes RA, Rees JH. (1997). Clinical and epidemiologic features of Guillain- Barré syndrome. Journal of Infectious Diseases. 176:392-8.
Levin KH. (2004). Variants and mimics of Guillain-Barré syndrome. Neurologist. 10:61-74.
Logullo F, Manicone M, Di Bella P, Provinciali L. (2006). Asymmetric Guillain-Barré syndrome. Neurological Sciences. 27:355-359.
Navarro F, Hanauer SB. (2003). Treatment of inflammatory bowel disease: safety and tolerability issues. American Journal of Gastroenterology. 98(12 Suppl):S18-23. Su CG, Judge TA, Lichtenstein GR. (2002). Extraintestinal manifestations of inflammatory bowel disease. Gastroenterology Clinics of North America. 31(1):307-327.
Zimmerman J, Steiner I, Gavish D, Argov Z. (1985). Guillain-Barré syndrome: a possible extraintestinal manifestation of ulcerative colitis. Journal of Clinical Gastroenterology. 7(4):301-303.